Combined

Males (52.6%)

Females (47.4%)

Trait

Deficient

Sufficient

p value*

Deficient

Sufficient

p value*

Deficient

Sufficient

p value*

(<50nmol/L)

( ≥ 50nmol/L)

(<50nmol/L)

( ≥ 50nmol/L)

(<50nmol/L)

( ≥ 50nmol/L)

Prevalence

(%)

(%)

 

(%)

(%)

 

(%)

(%)

 

Total (n=1,765)

75.8

24.2

p<0.0001

78.3

21.7

p<0.0001

72.6

27.4

p<0.0001

Type 2 Diabetes

83.51

16.5

p<0.0001

85

15

p<0.0001

81.6

18.4

p<0.0001

Normoglycemic controls

68.01

32.7

p<0.0001

71.5

28.5

p<0.0001

63.5

36.5

p<0.0001

BMI<23kg/m2

65.22

34.8

p<0.0001

68.7

31.3

p<0.0001

59.8

40.2

p=0.012

BMI 23-27.5kg/m2

75.52,3

24.5

p<0.0001

80.2

19.8

p<0.0001

68.6

31.4

p<0.0001

BMI>27.5kg/m2

81.43

18.6

p<0.0001

82.4

17.6

p<0.0001

80.4

19.6

p<0.0001

Hypertensive (>140/85)

78.24

21.8

p<0.0001

81.8

18.2

p<0.0001

73.8

26.2

p<0.0001

Non-Hypertensive

72.84

27.2

p<0.0001

74.1

25.9

p<0.0001

71.6

28.4

p<0.0001

 

β (95% CI)

p value

β (95% CI)

p valued

β (95% CI)

p valued

Type 2 Diabetes

-0.41 (-0.5, -0.3)

2.8 × 10-20a

-0.5 (-0.6, -0.4)

4.9 × 10-17

-0.3 (-0.4, -0.2)

3.6 × 10-7

Metabolic Traits

Fasting Glucose (mg/dL)

-0.18 (-0.3,-0.03)

0.022b

-0.01 (-0.04, 0.01)

0.31

-0.03 (-0.5, -0.003)

0.03

Fasting Insulin (µIU/mL)

0.04 (-0.01, 0.09)

0.145b

0.006 (0.07, 0.08)

0.89

0.08 (0.002, 0.2)

0.044

C Peptide (ng/mL)

0.09 (0.02,0.1)

0.017b

0.002 (0.1, 0.1)

0.97

0.21 (0.09, 0.3)

4.9 × 10-4

Amylin (pg/mL)

0.019 (-0.002,0.04)

0.071b

0.004 (0.03, 0.03)

0.82

0.04 (0.009, 0.06)

0.009

HOMA-B

0.17 (0.09,0.2)

8.0 × 10-6b

0.09 (0.001, 0.19)

0.05

0.2 (0.1, 0.3)

1.4 × 10-5

Obesity

BMI (kg/m2)

-0.71 (-0.9, -0.4)

1.4 × 10-7c

-0.6 (-0.9, -0.3)

3.8 × 10-4

-0.8 (-1.2, -0.4)

8.7 × 10-5

Cardiovascular Traits

Systolic BP (mmHg)

-1.68 (-2.9,-0.4)

0.006b

-3.2 (-4.9, -1.5)

1.8 × 10-4

-1.0 (-2.9, 0.7)

0.23

Diastolic BP (mmHg)

0.32 (0.3,0.9)

0.35b

0.2 (1.2, 0.8)

0.75

0.3 (0.6, 1.2)

0.56

Pulse Pressure (mmHg)

-1.85 (-2.8, -0.9)

1.2 × 10-4b

-3.1 (-4.3, -1.8)

2.3 × 10-6

-1.0 (-2.4, 0.4)

0.17

Prevalence *Chi-square analysis: 1T2Dvs Normoglycemic (p<0.0001); 2BMI<23 vs BMI 23-27.5 (p<0.0001); 3BMI 23-27.5 vs BMI>27.5 (p<0.0001); 4Hypertensive vs Non-Hypertensive (p<0.0001); Multiple Regression aLogistic regression adjusted for BMI, age, gender; bLinear regression adjusted for T2D, age, BMI and gender; cLinear regression adjusted for T2D, age and gender; dGender was excluded as co-variant
Table 1: Prevalence of vitamin D deficiency and the association of cardio-metabolic traits with 25(OH)D.